PMID: 6272135Jan 1, 1981Paper

Stimulus-dependent blockade of node of Ranvier sodium channels by ethmozine

Neir̆ofiziologiia = Neurophysiology
V M BolotinaB I Khodorov

Abstract

The effect of antiarrhythmic drug ethmozine on sodium channels in Ranvier node was studied by the voltage clamp technique. Both outside and inside application of ethmozine induced a decrease of sodium current I Na, the time course of I Na and the sodium inactivation being unchanged. The ethmozine-induced Na channel blockade induced tonic (stationary) and phasic (transient stimulus-dependent) components. The tonic blockade of I Na developed slowly and could be accelerated by frequent electric stimulation of the membrane. The phase dependent blockade became more profound with an increase in the pulse rate or amplitude of depolarizing pulses. The prolonged (1 s) membrane depolarization did not bring about an additional blockade of I Na. It is concluded that the phasic blockade is due to the interaction of ethmozine with open Na channels. The noninactivating batrachotoxin-modified Na channels were insensitive to ethmozine. It is found that the increase in outside potassium concentration from 2.5 to 20mM induced both a decrease of the tonic blockade and an increase of the phasic one. The possible nature of the ionic blockade is discussed. The effect of ethmozine is compared with that of tertiary and quaternary local anesthetics.

References

Jun 10, 1975·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·W Ulbricht, H H Wagner
Jun 1, 1977·The Journal of General Physiology·B I Shapiro
Mar 1, 1977·The Journal of General Physiology·J Z Yeh, T Narahashi
Jan 1, 1975·Annual Review of Physiology·D LandowneD A Terrar
Jul 1, 1973·The Journal of General Physiology·G R Strichartz
May 1, 1980·Biulleten' eksperimental'noĭ biologii i meditsiny·L D Zaborovskaia, B I Khodorov
Aug 29, 1958·The Journal of Physiology·F A DODGE, B FRANKENHAEUSER

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.